Fig. 1From: Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis BPatient disposition during the study. ACLF, acute-on-chronic liver failure; LAM, lamivudine; ETV, entecavir; TDF, tenofovir disoproxil fumarate; TAF, tenofovir alafenamideBack to article page